Free Trial

Edesa Biotech (EDSA) Institutional Ownership

Edesa Biotech logo
$14.78 -0.47 (-3.05%)
As of 03:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Edesa Biotech (NASDAQ:EDSA)

Current
Institutional Ownership
Percentage
5.50%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$3.53M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$23.42K
Get EDSA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Edesa Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

EDSA Institutional Buying and Selling by Quarter

Edesa Biotech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2026Diadema Partners LP54,025$77K0.0%N/A0.649%
2/13/2026State Street Corp18,679$27K0.0%N/A0.224%
2/12/2026DRW Securities LLC134,222$191K0.0%N/A1.611%
11/17/2025Susquehanna International Group LLP14,610$36K0.0%N/A0.208%
11/17/2025Citadel Advisors LLC14,032$34K0.0%-40.3%0.199%
5/15/2025Nantahala Capital Management LLC625,000$1.53M0.1%N/A8.899%
5/15/2025Velan Capital Investment Management LP687,500$1.68M1.7%N/A9.789%
5/14/2025Stonepine Capital Management LLC687,500$1.68M1.6%N/A9.789%
2/17/2025Citadel Advisors LLC40,944$70K0.0%N/A1.180%
2/14/2025Two Sigma Securities LLC15,313$26K0.0%N/A0.441%
8/2/2024CM Management LLC90,000$385K0.3%+45.2%2.795%
11/7/2023CM Management LLC417,602$264K0.3%+11.4%13.874%
8/4/2023CM Management LLC375,000$304K0.3%+15.4%1.821%
5/8/2023CM Management LLC325,000$296K0.4%+3.9%1.620%
2/14/2023Susquehanna International Group LLP15,211$33K0.0%N/A0.079%
2/9/2023CM Management LLC312,773$676K0.8%+25.1%1.616%
2/7/2023Lynwood Capital Management Inc.121,845$264K0.3%N/A0.630%
11/4/2022CM Management LLC250,000$230K0.3%N/A1.617%
8/8/2022Merit Financial Group LLC20,409$33K0.0%N/A0.132%
5/5/2022National Bank of Canada FI10,000$30K0.0%+1,518.1%0.072%


EDSA Institutional Ownership - Frequently Asked Questions

During the previous two years, 10 institutional investors and hedge funds held shares of Edesa Biotech. The most heavily invested institutionals were Velan Capital Investment Management LP ($1.68M), Stonepine Capital Management LLC ($1.68M), Nantahala Capital Management LLC ($1.53M), CM Management LLC ($385K), DRW Securities LLC ($191K), Diadema Partners LP ($77K), and Susquehanna International Group LLP ($36K).Learn more on Edesa Biotech's institutional investors.

5.50% of Edesa Biotech's stock is owned by institutional investors. Learn more on EDSA's institutional investor holdings.

Of the 10 institutional investors that purchased Edesa Biotech's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Stonepine Capital Management LLC ($687.50K), Velan Capital Investment Management LP ($687.50K), Nantahala Capital Management LLC ($625K), DRW Securities LLC ($134.22K), Diadema Partners LP ($54.03K), Citadel Advisors LLC ($40.94K), and CM Management LLC ($28K).

Institutional investors have bought a total of 1,534,036 shares in the last 24 months. This purchase volume represents approximately $3.53M in transactions.

The following institutional investors have sold Edesa Biotech stock in the last 24 months: Citadel Advisors LLC ($9.48K).

Institutional investors have sold a total of 9,482 shares in the last 24 months. This volume of shares sold represents approximately $23.42K in transactions.



This page (NASDAQ:EDSA) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners